We started this week with Mathews reporting on the stay granted by the IPAB on the Chennai Patent Office’s order revoking Pfizer’s patent in the drug Detrol (read our original post here). The IPAB reasons that the balance of convenience is very much in favour of the petitioner for granting the relief of stay and that Ranbaxy had adequate time to appear and argue the matter and that there was no need to delay the matter any longer. Anubha then...
↧